Journal Article10.1007/S12032-012-0411-9
MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma
Jian Sun,Zhaoli Chen,Xiaogang Tan,Fang Zhou,Fengwei Tan,Yibo Gao,Nan Sun,Xiaohui Xu,Kang Shao,Jie He +9 more
107
TL;DR: Results indicated thatmiR-99a and miR-100 inhibited cell proliferation by suppressing mTOR in ESCC cell lines, and therefore, the miR -99a/100-mTOR signaling pathway is a potential therapeutic target for inducing apoptosis to combat ESCC.
read more
Abstract: Recently, microRNA-99 family members, such as miR-99a/b and miR-100, have been reported to exhibit abnormal expression in various malignant tumors, but their functions in carcinomas are controversial. In this study, we focused on miR-99a and miR-100, which were determined to be universally downregulated in esophageal squamous cell carcinoma, and investigated their functions and potential mechanisms of action. The downregulation of miR-99a/100 was validated by qRT-PCR in 101 ESCC surgical tissue samples and in 3 ESCC cell lines. The overexpression of miR-99a and miR-100 via the transient transfection of the corresponding precursor molecules inhibited cell proliferation by inducing apoptosis in the ESCC cell lines. To investigate the molecular mechanism of miR-99a/100-induced apoptosis, luciferase reporter assays and Western blots were performed to demonstrate that the overexpression of miR-99a/100 suppressed the expression of mTOR by directly targeting its 3'UTR in a post-transcriptional manner. Clinically, the decreased expression of miR-99a/100 was associated with worse overall survival in ESCC patients. In conclusion, these results indicated that miR-99a and miR-100 inhibited cell proliferation by suppressing mTOR in ESCC cell lines, and therefore, the miR-99a/100-mTOR signaling pathway is a potential therapeutic target for inducing apoptosis to combat ESCC.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. [Erratum: 2004 Sept. 23, v. 431, no. 7007, p. 485.]
Sung Hee Um,Francesca Frigerio,Mitsuhiro Watanabe,Frédéric Picard,Manel Joaquin,Melanie Sticker,Stefano Fumagalli,Peter R. Allegrini,Sara C. Kozma,Johan Auwerx +9 more
TL;DR: In this article, S6K1-deficient mice are protected against obesity owing to enhanced β-oxidation, but on a high fat diet, levels of glucose and free fatty acids still rise in S6k1-dependent mice, resulting in insulin receptor desensitization.
1.4K
Mechanically-sensitive miRNAs bias human mesenchymal stem cell fate via mTOR signalling.
Jessica E. Frith,Gina D. Kusuma,James Carthew,Fanyi Li,Nicole Cloonan,Guillermo A. Gomez,Justin J. Cooper-White +6 more
TL;DR: The authors identify miRNAs that change expression in response to substrate stiffness and RhoA signalling and show that they can bias MSC fate in a 3D soft hydrogel and provide mechanistic insight by demonstrating convergence on mTOR signalling.
Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Caiyun Wu,Cheng Wang,Xiaocui Guan,Yuxiu Liu,Demin Li,Xiaojun Zhou,Yanni Zhang,Xi Chen,Junjun Wang,Ke Zen,Chen-Yu Zhang,Chunni Zhang +11 more
TL;DR: The seven serum miRNAs found to be significantly higher in ESCC than in controls could potentially serve as novel biomarkers for ESCC; moreover, specific mi RNAs such as miR-25 andMiR-100 can predict poor survival in ES CC.
MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
TL;DR: It is demonstrated that miR-99a antitumor activity is achieved by targeting the mTOR/p-4E-BP1/ p-S6K1 pathway in human breast cancer cells.
MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer
TL;DR: The results suggested that the over-expressed microRNA-451 in colon cancer cells might inhibit AMPK to activate mTORC1, which mediates FSCN1 expression and cancer cell progression.
95
References
MicroRNAs: Genomics, Biogenesis, Mechanism, and Function
TL;DR: Although they escaped notice until relatively recently, miRNAs comprise one of the more abundant classes of gene regulatory molecules in multicellular organisms and likely influence the output of many protein-coding genes.
36.3K
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
22.9K
MicroRNAs: small RNAs with a big role in gene regulation
Lin He,Gregory J. Hannon +1 more
TL;DR: Two founding members of the microRNA family were originally identified in Caenorhabditis elegans as genes that were required for the timed regulation of developmental events and indicate the existence of multiple RISCs that carry out related but specific biological functions.
mTOR Signaling in Growth Control and Disease
Mathieu Laplante,David M. Sabatini +1 more
- 01 Apr 2012
TL;DR: The mechanistic target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis as mentioned in this paper, and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration.
6.8K
mTOR signaling in growth control and disease.
TL;DR: Recent advances in understanding of the mTOR pathway are reviewed and pharmacological approaches to treat human pathologies linked to mTOR deregulation are discussed.
5.7K